Janus Henderson Group
NVCR icon

Janus Henderson Group’s NovoCure NVCR Stock Holding History

Janus Henderson Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$491K Hold
45,000
– – ﹤0.01% 2012
2025
Q4 		$582K Hold
45,000
– – ﹤0.01% 1954
2025
Q3 		$582K Hold
45,000
– – ﹤0.01% 1935
2025
Q2 		$802K Hold
45,000
– – ﹤0.01% 1716
2025
Q1 		$848K Sell
45,000
-5,200
-10% -$118K ﹤0.01% 1704
2024
Q4 		$1.5M Hold
50,200
– – ﹤0.01% 1469
2024
Q3 		$784K Hold
50,200
– – ﹤0.01% 1791
2024
Q2 		$858K Sell
50,200
-10,200
-17% -$179K ﹤0.01% 1700
2024
Q1 		$943K Buy
60,400
+2
+0% +$29 ﹤0.01% 1675
2023
Q4 		$902K Sell
60,398
-125
-0.2% -$1.67K ﹤0.01% 1682
2023
Q3 		$977K Buy
60,523
+49,945
+472% +$1.44M ﹤0.01% 1566
2023
Q2 		$439K Sell
10,578
-1,166
-10% -$72.4K ﹤0.01% 2051
2023
Q1 		$706K Sell
11,744
-14,701
-56% -$1.17M ﹤0.01% 1821
2022
Q4 		$1.94M Buy
26,445
+15,371
+139% +$1.16M ﹤0.01% 1106
2022
Q3 		$841K Sell
11,074
-1,900
-15% -$148K ﹤0.01% 1364
2022
Q2 		$902K Sell
12,974
-1,222
-9% -$92.1K ﹤0.01% 1395
2022
Q1 		$1.18M Sell
14,196
-6,037
-30% -$445K ﹤0.01% 1427
2021
Q4 		$1.52M Sell
20,233
-36,134
-64% -$3.63M ﹤0.01% 1354
2021
Q3 		$6.55M Buy
56,367
+26,625
+90% +$4.03M ﹤0.01% 990
2021
Q2 		$6.6M Sell
29,742
-19,519
-40% -$3.8M ﹤0.01% 1004
2021
Q1 		$6.51M Buy
49,261
+43,647
+777% +$6.9M ﹤0.01% 970
2020
Q4 		$969K Buy
+5,614
New +$768K ﹤0.01% 1206

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Janus Henderson Group's NVCR Position: Q1 2026 in Review

Janus Henderson Group held its NovoCure (NVCR) position steady in Q1 2026 at 45,000 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #2012.

Janus Henderson Group first reported a position in NVCR in Q4 2020 and has held it in 22 quarters since. The position peaked at $6.6M in Q2 2021. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Janus Henderson Group held 45,000 shares of NovoCure worth $491K as of Q1 2026.
  • Janus Henderson Group left its NovoCure share count unchanged in Q1 2026.
  • NovoCure made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2012 holding.
  • Janus Henderson Group first reported a position in NovoCure in Q4 2020 and has held it in 22 quarters since.
  • Janus Henderson Group's NovoCure position peaked at $6.6M in Q2 2021.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.